Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-23-006069
Filing Date
2023-04-17
Accepted
2023-04-17 16:35:52
Documents
5
Effectiveness Date
2023-04-17

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20230417xs8.htm S-8 129050
2 EX-5.1 tmb-20230417xex5d1.htm EX-5.1 9578
3 EX-23.1 tmb-20230417xex23d1.htm EX-23.1 3582
4 EX-FILING FEES tmb-20230417xexfilingfees.htm EX-FILING FEES 40663
5 GRAPHIC tmb-20230417xex5d1001.jpg GRAPHIC 3556
  Complete submission text file 0001558370-23-006069.txt   189041
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-271292 | Film No.: 23824384
SIC: 2834 Pharmaceutical Preparations